Chronic treatment with agents that stabilize cytosolic IκB-α enhances survival and improves resting membrane potential in MDX muscle fibers subjected to chronic passive stretch
- 31 December 2005
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 20 (3) , 719-730
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Interleukin-1 β inhibits Na+-K+ATPase activity and protein expression in cardiac myocytesCytokine, 2004
- Gabexate Mesilate, a Synthetic Protease Inhibitor, Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production by Inhibiting Activation of Both Nuclear Factor-κB and Activator Protein-1 in Human MonocytesThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Interleukin-1 β Increases Urine Flow Rate and Inhibits Protein Expression of Na + /K + -ATPase in the Rat Jejunum and KidneyJournal of Interferon & Cytokine Research, 2002
- Inhibition of Tumor Necrosis Factor-α-induced Nuclear Translocation and Activation of NF-κB by DehydroxymethylepoxyquinomicinJournal of Biological Chemistry, 2002
- RETRACTED: Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammationBritish Journal of Pharmacology, 2002
- Muscle contractions induce interleukin‐6 mRNA production in rat skeletal musclesThe Journal of Physiology, 2000
- Inhibition of nuclear factor-κB activation reduces cortical tubulointerstitial injury in proteinuric ratsKidney International, 1999
- A non‐capacitative pathway activated by arachidonic acid is the major Ca2+ entry mechanism in rat A7r5 smooth muscle cells stimulated with low concentrations of vasopressinThe Journal of Physiology, 1999
- Mechanical advantage of the human parasternal intercostal and triangularis sterni musclesThe Journal of Physiology, 1998
- Structure, Regulation and Function of NF-kappaBAnnual Review of Cell Biology, 1994